Saturday 11 April 2026

One To Watch

Vittoria Biotherapeutics

A clinical-stage cell therapy company developing novel CAR-T cell therapies.

Company Overview

Want to Update your Company's Profile?


Latest Vittoria Biotherapeutics News

ASH 2024: Hematologists ready for big showcase
1 December 2024
Vittoria Bio appoints seasoned biotech leader as COO
16 April 2024
Vittoria Bio appoints Rosemary Mazanet as chief medical officer
27 February 2024
More Vittoria Biotherapeutics news >


Today's issue

BioNTech and DualityBio’s ADC success
Biotechnology
BioNTech and DualityBio’s ADC success
11 April 2026
Pharmaceutical
MHRA approves Tryngolza for FCS
11 April 2026
Pharmaceutical
Boehringer hands CT-155 rights to Click in schizophrenia pivot
10 April 2026
Biotechnology
Daiichi taps Imagene to sharpen cancer biomarker discovery
10 April 2026
Pharmaceutical
Annovis secures financing for buntanetap’s NDA submission
10 April 2026
Pharmaceutical
Tempus AI expands collaboration with Gilead
10 April 2026
Pharmaceutical
Medicines Australia firmly opposes US tariffs on pharmaceuticals
10 April 2026




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze